DeepMind’s bold drug discovery promise
DeepMind’s CEO, Demis Hassabis, told Bloomberg that artificial intelligence will radically accelerate the process of drug discovery, which has long plagued the pharmaceutical industry with its slow and costly dynamics. If the promises hold true, drug development could shrink from over a decade to just a few months. At the center of this approach are […]